A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...

For DOJ Undersecretary Ian Dato, weekends are sacred time with his family—wife Giorgia Guidicelli-Dato, and daughters Vivi, 3, and Gianna, 5. Photo courtesy of Atty. Ian Dato. Fatherhood is both a ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Residents of Taman Dato Harun, Petaling Jaya, protested against the construction of a Hindu temple in the area today, citing the neighbourhood’s demographic makeup and traffic concerns as grounds for ...

Pooja Dave began her writing career in fiction before turning to financial journalism with an interest in personal finance and insurance topics. Charlene Rhinehart is a CPA , CFE, chair of an Illinois ...

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.

Yema has given its iconic diver a thoughtful upgrade with the new Superman Dato CMM.10, which appears to be a quiet evolution in design and mechanics rather than a radical departure. Available in two ...

With 42 years of experience, Dato' Lau leads the health care division of the Sunway Group. Sunway Healthcare Group (SHG) currently has five hospitals around Malaysia, specialist day ambulatory care ...

Adobe InDesign is the standard-bearer for layout, page, and publication design software, and a must-have for any creative professional. Part of Adobe’s Creative Cloud suite, InDesign is an ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A next-generation form of ...

AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at the second attempt. The partners showed off subgroup overall survival data ...